森下仁丹の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/01/17 | 1,880 | 1,894 | 1,880 | 1,884 | -19 | -1% | 4,400 |
| 2022/01/14 | 1,903 | 1,903 | 1,900 | 1,903 | ±0 | ±0% | 500 |
| 2022/01/13 | 1,902 | 1,903 | 1,902 | 1,903 | +3 | +0.2% | 200 |
| 2022/01/12 | 1,901 | 1,903 | 1,888 | 1,900 | -3 | -0.2% | 1,500 |
| 2022/01/11 | 1,900 | 1,903 | 1,895 | 1,903 | +3 | +0.2% | 600 |
| 2022/01/07 | 1,900 | 1,905 | 1,896 | 1,900 | ±0 | ±0% | 1,000 |
| 2022/01/06 | 1,898 | 1,904 | 1,898 | 1,900 | +2 | +0.1% | 1,700 |
| 2022/01/05 | 1,900 | 1,905 | 1,898 | 1,898 | -2 | -0.1% | 1,100 |
| 2022/01/04 | 1,896 | 1,916 | 1,895 | 1,900 | +4 | +0.2% | 3,400 |
| 2021/12/30 | 1,888 | 1,896 | 1,885 | 1,896 | +11 | +0.6% | 400 |
| 2021/12/29 | 1,886 | 1,887 | 1,873 | 1,885 | +20 | +1.1% | 2,200 |
| 2021/12/28 | 1,874 | 1,875 | 1,862 | 1,865 | -4 | -0.2% | 5,300 |
| 2021/12/27 | 1,870 | 1,878 | 1,860 | 1,869 | +3 | +0.2% | 5,300 |
| 2021/12/24 | 1,862 | 1,871 | 1,860 | 1,866 | +4 | +0.2% | 2,000 |
| 2021/12/23 | 1,872 | 1,872 | 1,862 | 1,862 | +1 | +0.1% | 2,500 |
| 2021/12/22 | 1,866 | 1,871 | 1,861 | 1,861 | -8 | -0.4% | 2,700 |
| 2021/12/21 | 1,870 | 1,874 | 1,867 | 1,869 | -1 | -0.1% | 2,700 |
| 2021/12/20 | 1,878 | 1,878 | 1,870 | 1,870 | -5 | -0.3% | 1,400 |
| 2021/12/17 | 1,876 | 1,879 | 1,871 | 1,875 | +1 | +0.1% | 1,900 |
| 2021/12/16 | 1,876 | 1,877 | 1,874 | 1,874 | -2 | -0.1% | 1,700 |
| 2021/12/15 | 1,885 | 1,887 | 1,875 | 1,876 | -8 | -0.4% | 2,200 |
| 2021/12/14 | 1,885 | 1,885 | 1,875 | 1,884 | -1 | -0.1% | 1,000 |
| 2021/12/13 | 1,889 | 1,889 | 1,876 | 1,885 | -5 | -0.3% | 1,800 |
| 2021/12/10 | 1,874 | 1,900 | 1,873 | 1,890 | +17 | +0.9% | 1,800 |
| 2021/12/09 | 1,875 | 1,884 | 1,873 | 1,873 | -6 | -0.3% | 2,300 |
| 2021/12/08 | 1,886 | 1,886 | 1,872 | 1,879 | +4 | +0.2% | 3,700 |
| 2021/12/07 | 1,879 | 1,880 | 1,875 | 1,875 | ±0 | ±0% | 1,700 |
| 2021/12/06 | 1,880 | 1,880 | 1,875 | 1,875 | -8 | -0.4% | 1,100 |
| 2021/12/03 | 1,879 | 1,884 | 1,868 | 1,883 | +17 | +0.9% | 3,500 |
| 2021/12/02 | 1,861 | 1,887 | 1,861 | 1,866 | -2 | -0.1% | 1,300 |
| 2021/12/01 | 1,876 | 1,882 | 1,860 | 1,868 | -21 | -1.1% | 3,000 |
| 2021/11/30 | 1,887 | 1,890 | 1,884 | 1,889 | +8 | +0.4% | 1,100 |
| 2021/11/29 | 1,888 | 1,891 | 1,880 | 1,881 | -8 | -0.4% | 1,500 |
| 2021/11/26 | 1,888 | 1,889 | 1,885 | 1,889 | ±0 | ±0% | 2,900 |
| 2021/11/25 | 1,889 | 1,892 | 1,889 | 1,889 | -1 | -0.1% | 1,800 |
| 2021/11/24 | 1,890 | 1,893 | 1,890 | 1,890 | ±0 | ±0% | 1,300 |
| 2021/11/22 | 1,893 | 1,893 | 1,890 | 1,890 | -3 | -0.2% | 1,500 |
| 2021/11/19 | 1,900 | 1,900 | 1,893 | 1,893 | +2 | +0.1% | 1,700 |
| 2021/11/18 | 1,892 | 1,892 | 1,891 | 1,891 | -2 | -0.1% | 700 |
| 2021/11/17 | 1,892 | 1,893 | 1,892 | 1,893 | -4 | -0.2% | 700 |
| 2021/11/16 | 1,896 | 1,897 | 1,896 | 1,897 | +3 | +0.2% | 400 |
| 2021/11/15 | 1,898 | 1,899 | 1,894 | 1,894 | +4 | +0.2% | 1,100 |
| 2021/11/12 | 1,889 | 1,890 | 1,889 | 1,890 | +3 | +0.2% | 400 |
| 2021/11/11 | 1,896 | 1,896 | 1,887 | 1,887 | -11 | -0.6% | 5,000 |
| 2021/11/10 | 1,897 | 1,905 | 1,897 | 1,898 | -3 | -0.2% | 2,400 |
| 2021/11/09 | 1,910 | 1,910 | 1,898 | 1,901 | -9 | -0.5% | 2,700 |
| 2021/11/08 | 1,899 | 1,950 | 1,899 | 1,910 | +10 | +0.5% | 6,600 |
| 2021/11/05 | 1,899 | 1,903 | 1,899 | 1,900 | +1 | +0.1% | 500 |
| 2021/11/04 | 1,905 | 1,905 | 1,899 | 1,899 | -1 | -0.1% | 800 |
| 2021/11/02 | 1,900 | 1,905 | 1,900 | 1,900 | -3 | -0.2% | 800 |
701～
750
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「仁 丹」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 仁 丹 | 211,400円 | +2.4% | +10.4% | 2.60% | 12.36倍 | 0.69倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
| ラクオリア | 46,200円 | +138.6% | - | 0.00% | 42.35倍 | 1.78倍 |
|
ファイザー旧国内研究所が前身。導出した発売済み消化器薬等収益柱に成長、低分子創薬に強い |
| モダリス | 14,100円 | - | - | 0.00% | - | 8.93倍 |
|
遺伝子治療薬の創薬ベンチャー、切断しない独自のゲノム編集技術に強み。研究開発中心は米国 |
| ＯＴＳ | 3,200円 | +63.9% | - | 0.00% | - | 9.38倍 |
|
がん治療ワクチン創薬ベンチャー。大手製薬と開発提携。東大医科研発。会社計画は非開示 |
| ケイファーマ | 73,000円 | -100.0% | - | 0.00% | - | 3.16倍 |
|
慶応大学発医療ベンチャー。ｉＰＳ細胞による再生医療と創薬の２本柱。中枢神経系が得意領域 |
市場注目の銘柄
チャート関連のコラム
